Flag­ship builds a new start­up out of pieces from 2 of its biotechs. And a Roche vet leaves to do some­thing new

Flag­ship has craft­ed a new start­up out of pieces from a pair of fledg­lings in the VC’s nest. And a promi­nent Roche vet­er­an who ran one of the biotechs won’t be mak­ing the next leg of the jour­ney.

The new com­pa­ny is called Sonata Ther­a­peu­tics, which is pick­ing up the work that Inzen was do­ing re­lat­ed to the cel­lu­lar mi­croen­vi­ron­ment and com­bin­ing with Flag­ship’s Cyg­nal Ther­a­peu­tics, which came out of stealth more than 3 years ago and put Pearl Huang — the BeiGene founder and for­mer Roche SVP — at the helm.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER